Centessa Pharmaceuticals plc
NASDAQ:CNTA
15.81 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -151.671 | -216.207 | -381.854 | -10.663 | -5.061 |
| Depreciation & Amortization
| 0.813 | 0.131 | 0.034 | 0 | 0.006 |
| Deferred Income Tax
| -26.632 | -2.857 | -6.804 | 0 | 0.001 |
| Stock Based Compensation
| 29.392 | 24.965 | 14.852 | 0.336 | 0.236 |
| Change In Working Capital
| -18.903 | -2.831 | -5.378 | -0.489 | -1.006 |
| Accounts Receivables
| -12.139 | -11.704 | -6.721 | 0 | 0 |
| Inventory
| -0 | 11.704 | -4.157 | 0 | 0 |
| Accounts Payables
| -2.733 | 6.351 | 4.157 | -0.049 | 0.855 |
| Other Working Capital
| -4.032 | -9.182 | 1.343 | -0.44 | -1.861 |
| Other Non Cash Items
| 6.037 | -3.747 | 257.846 | 0.186 | -0.001 |
| Operating Cash Flow
| -160.963 | -200.546 | -136.142 | -10.63 | -5.825 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.17 | -1.137 | -0.186 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 63.434 | 0 | 0 |
| Purchases Of Investments
| -265.937 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 138.61 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0.206 | -0 | 0 | 0 |
| Investing Cash Flow
| -127.496 | -0.931 | 63.248 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | -73.638 | -5.039 | -3.831 |
| Common Stock Issued
| 21.199 | 0.718 | 586.442 | 0.01 | 0 |
| Common Stock Repurchased
| 0 | 0 | -0.012 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 21.117 | -0.261 | 586.217 | 6.391 | 9.005 |
| Financing Cash Flow
| 21.199 | 0.457 | 660.068 | 1.362 | 9.005 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0.615 | -0.418 | 1.902 | -0.075 | 0.52 |
| Net Change In Cash
| -265.614 | -201.438 | 590.079 | -9.343 | 3.7 |
| Cash At End Of Period
| 128.03 | 393.644 | 595.082 | 7.227 | 16.57 |